| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.25B | 54.41B | 56.66B | 53.52B | 51.19B | 43.96B |
| Gross Profit | 5.94B | 5.79B | 5.98B | 4.37B | 5.37B | 5.00B |
| EBITDA | 3.57B | 2.52B | 4.68B | 2.85B | 3.90B | 3.56B |
| Net Income | -877.00M | -1.20B | 332.00M | -2.06B | 783.00M | -191.00M |
Balance Sheet | ||||||
| Total Assets | 52.34B | 53.13B | 56.54B | 52.18B | 50.48B | 49.20B |
| Cash, Cash Equivalents and Short-Term Investments | 5.68B | 4.14B | 4.27B | 3.94B | 4.23B | 4.17B |
| Total Debt | 7.48B | 8.11B | 9.49B | 9.07B | 7.55B | 8.70B |
| Total Liabilities | 23.54B | 24.01B | 27.18B | 24.65B | 21.99B | 22.86B |
| Stockholders Equity | 27.93B | 28.25B | 28.61B | 26.91B | 27.99B | 25.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.49B | -321.00M | -1.43B | 1.80B | 3.17B |
| Operating Cash Flow | 0.00 | 3.89B | 3.16B | 2.54B | 4.29B | 5.57B |
| Investing Cash Flow | 0.00 | -2.32B | -2.52B | -3.85B | -2.34B | -2.44B |
| Financing Cash Flow | 0.00 | -1.89B | -372.00M | 958.00M | -1.84B | -1.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | ¥11.55B | 2.84 | ― | 4.12% | -1.52% | -7.80% | |
75 Outperform | ¥13.39B | 6.74 | ― | 3.90% | -1.72% | 168.62% | |
71 Outperform | ¥18.37B | 8.04 | ― | 2.70% | -8.63% | -55.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥18.68B | 18.77 | ― | 3.19% | -8.99% | -62.26% | |
56 Neutral | ¥11.85B | 8.29 | ― | 2.23% | -4.06% | ― | |
54 Neutral | ¥14.85B | 3.20 | ― | 2.45% | -2.67% | 33.63% |